Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Cell Therapeutics (LCTX) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Cell Therapeutics (LCTX) lobbying for?
Summary:
– Company: Cell Therapeutics
– Lobbying Firms: Denny Miller Associates
– General Issues: Financial Institutions/Investments/Securities, Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
– Specific Issues: Approval of new drugs, European Union approval of US cancer drugs, FDA appeal process for new drug applications, FDA process for approving clinical trials for new drug applications, Federal support for biotechnology companies, Prescription Drug and User Fee Act Reauthorization, H.R. 4132 – Faster Access to Specialized Treatments Act, S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, Issues involving American Companies listed on foreign stock exchange, S. 3187, Issues related to prescription drug development
– Government Agencies: Senate, House of Representatives
One could infer that Cell Therapeutics is lobbying on these issues to promote their products and gain faster approvals for their new drugs in order to sell them in the market. They may also be lobbying for more government support for biotechnology companies and for policies that would benefit American companies listed on foreign stock exchanges. Additionally, Cell Therapeutics is likely lobbying for faster access to specialized treatments and for improvements in the FDA’s process for approving clinical trials and new drugs.
